Literature DB >> 11275265

The role of hepatocytes in the clearance of liposomes from the blood circulation.

G L Scherphof1, J A Kamps.   

Abstract

In this chapter we summarize literature and describe in more detail our own observations over a period of nearly two decennia on the role of hepatocytes in the hepatic clearance of intravenously administered liposomes. Evidence is presented indicating that, although size is an important parameter, it is not decisive in determining access of liposomes to the hepatocytes. Also lipid composition is an important parameter, including charge, rigidity and headgroup composition. The role of the fenestrated sinusoidal endothelial cells in determining liposome accessibility of hepatocytes is discussed as well as the involvement of opsonizing plasma proteins such as apolipoprotein E. Our observations led us to postulate the existence of at least four different mechanisms of interaction of liposomes with hepatocytes, i.e. an endocytic and a non-endocytic one for both neutral and negatively charged vesicles

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275265     DOI: 10.1016/s0163-7827(00)00020-5

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  12 in total

Review 1.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

Review 2.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

3.  Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study.

Authors:  Anke E Kip; Séverine Blesson; Fabiana Alves; Monique Wasunna; Robert Kimutai; Peninah Menza; Bewketu Mengesha; Jos H Beijnen; Asrat Hailu; Ermias Diro; Thomas P C Dorlo
Journal:  J Antimicrob Chemother       Date:  2021-04-13       Impact factor: 5.790

Review 4.  Nanoparticle ligand presentation for targeting solid tumors.

Authors:  Jason T Duskey; Kevin G Rice
Journal:  AAPS PharmSciTech       Date:  2014-06-14       Impact factor: 3.246

5.  Liposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparan sulfate.

Authors:  Kenneth J Longmuir; Sherry M Haynes; Janie L Baratta; Natasha Kasabwalla; Richard T Robertson
Journal:  Int J Pharm       Date:  2009-08-05       Impact factor: 5.875

6.  Ex-vivo activation of a liposomal prodrug of mitomycin C by human tumors.

Authors:  Shira Dorot; James Tankel; Victoria Doviner; Hilary Shmeeda; Yasmine Amitay; Patricia Ohana; Amir Dagan; Menachem Ben-Haim; Petachia Reissman; Alberto Gabizon
Journal:  Cancer Chemother Pharmacol       Date:  2022-07-08       Impact factor: 3.288

Review 7.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

Authors:  Nicolas Bertrand; Jun Wu; Xiaoyang Xu; Nazila Kamaly; Omid C Farokhzad
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470

Review 8.  Nanoparticles in pregnancy: the next frontier in reproductive therapeutics.

Authors:  Natasha Pritchard; Tu'uhevaha Kaitu'u-Lino; Lynda Harris; Stephen Tong; Natalie Hannan
Journal:  Hum Reprod Update       Date:  2021-02-19       Impact factor: 17.179

9.  Determination of Liposomal Cisplatin by High-Performance Liquid Chromatography and Its Application in Pharmacokinetic Studies.

Authors:  Alfonso Toro-Córdova; Fabricio Ledezma-Gallegos; Laura Mondragon-Fuentes; Rafael Jurado; Luis A Medina; Jazmin M Pérez-Rojas; Patricia Garcia-Lopez
Journal:  J Chromatogr Sci       Date:  2016-03-24       Impact factor: 1.618

10.  Creation of lung-targeted dexamethasone immunoliposome and its therapeutic effect on bleomycin-induced lung injury in rats.

Authors:  Xue-Yuan Chen; Shan-Mei Wang; Nan Li; Yang Hu; Yuan Zhang; Jin-Fu Xu; Xia Li; Jie Ren; Bo Su; Wei-Zhong Yuan; Xin-Rong Teng; Rong-Xuan Zhang; Dian-Hua Jiang; Xavier Mulet; Hui-Ping Li
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.